Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
PLoS One ; 12(12): e0189344, 2017.
Article de Anglais | MEDLINE | ID: mdl-29232404

RÉSUMÉ

Liver fibrosis represents the consequences of a sustained wound healing response to chronic liver injury which could be caused by viral, autoimmune, drugs, and so on. Unfortunately, there was no effective therapy available for liver fibrosis in clinic. In this study, we identified the anti-fibrotic effects of 1,7-dihydroxy-3,4,8-trimethoxyxanthone (ZYC-1) on the dimethylnitrosamine (DMN)-induced rat model. ZYC-1 was isolated from Swertia punicea Hemsl and was administrated to DMN-induced rat model. ZYC decreased the hyaluronic acid (HA), type IV collagen (CIV) and hydroxyproline (Hyp) levels and inhibited the expression of α smooth muscle actin (α-SMA) and transforming growth factor beta 1 (TGF-1ß). The anti-fibrotic effect of ZYC-1 was also confirmed by Sirius Red staining. Finally, we identified 42 differentially expressed proteins by using proteomics analysis after ZYC-1 treatment, of which 17 were up-regulated and 25 were down-regulated. These Most of the 42 proteins are involved in the oxidative stress pathway, the mitochondrial-mediated apoptotic pathway and the amino acid metabolism pathway. Our study presented the first elucidated mechanisms of xanthone on liver fibrosis in vivo. This study pointed out that ZYC-1 may be used as a lead compound for hepatofibrosis treatment.


Sujet(s)
Acides aminés/analyse , Antioxydants/pharmacologie , Apoptose/effets des médicaments et des substances chimiques , N-Méthyl-N-nitroso-méthanamine/toxicité , Cirrhose du foie/prévention et contrôle , Xanthones/pharmacologie , Animaux , Cirrhose du foie/induit chimiquement , Mâle , Rats , Rat Sprague-Dawley
2.
Zhongguo Zhong Yao Za Zhi ; 41(9): 1725-1731, 2016 May.
Article de Chinois | MEDLINE | ID: mdl-28891625

RÉSUMÉ

To investigate the effect of Fuzheng Huayu capsule(FHC) on serum metabolomics in rats with liver fibrosis induced by dimethylnitrosamine(DMN). The metabolic profiles of rat serum of normal group, model group, and FHC group were established by liquid chromatography-mass spectrometry technology. Furthermore, the levels of endogenous metabolites such as amino acids and bile acids were measured in each group. The results showed that there were significant differences in the serum metabolic fingerprints between the FHC group and the model group. Moreover, 5 potential lysophosphatidylcholines biomarkers were identified by using principal component analysis(PCA) and partial least squares discriminant analysis (PLS-DA). Quantitative analysis of amino acids and bile acids in serum of rats showed that 14 kinds of amino acids and 5 kinds of bile acids returned to normal levels after four weeks of FHC treatment. In conclusion, the anti-hepatic fibrosis mechanisms of FHC may be related to the metabolic process of lysophosphatidylcholines, amino acids and bile acids.


Sujet(s)
Médicaments issus de plantes chinoises/pharmacologie , Cirrhose du foie/traitement médicamenteux , Métabolome , Animaux , N-Méthyl-N-nitroso-méthanamine/toxicité , Foie/effets des médicaments et des substances chimiques , Cirrhose du foie/induit chimiquement , Rats , Rat Wistar , Sérum/métabolisme
3.
J Ethnopharmacol ; 153(3): 854-63, 2014 May 14.
Article de Anglais | MEDLINE | ID: mdl-24690777

RÉSUMÉ

ETHNOPHARMACOLOGICAL RELEVANCE: Swertia punicea Hemsl. (Gentianaceae) is more commonly known as "Ganyan-cao" and used mainly as a traditional Chinese folk medicine for the treatment of acute bilious hepatitis, cholecystitis, fever, intoxification and jaundice. MATERIALS AND METHODS: The active hepatoprotective constituents of Swertia punicea were purified using various column chromatography techniques. The structures of two isolated compounds were determined on the basis of spectroscopic data interpretation such as NMR analysis. The hepatoprotective activities of isolated compounds were evaluated by using hepatotoxicity in vitro and dimethylnitrosamine-induced rat hepatic fibrosis in vivo, respectively. RESULTS: Two xanthones, 1, 7-dihydroxy-3, 4, 8-trimethoxyxanthone (1) and bellidifolin (2) were isolated from the stems of Swertia punicea. The compounds 1 and 2 exhibited notable hepatoprotective activities against carbon tetrachloride (CCl4) -induced HepG2 cell damage, and effectively alleviated the levels of aspartate transaminase (AST), lactate dehydrogenase (LDH), superoxide dismutase (SOD) and malonic dialdehyde (MDA) induced by CCl4 in a concentration-dependent manner. Co-treatment with compound 2 significantly increased the cell viability compared with N-acetyl-p-aminophenol (APAP) treatment. Compound 2 also alleviated APAP-induced hepatotoxicity by increasing glutathione (GSH) content and decreasing hydroxyl free radical (·OH) levels and reactive oxygen specises (ROS) production. In addition, the protective effect of compound 1 significantly alleviated DMN-induced liver inflammation and fibrosis. Oral administration of compound 1 recovered the reduction of albumin (ALB) and reversed the elevation of serum alanine transaminase (ALT), AST and total bilirubin (TBIL) in dimethylnitrosamine (DMN)-induced fibrotic rats. Severe oxidative stress induced in fibrotic rats was evidenced by a 1.5-fold elevation in MDA and a fall in the SOD activity, and treatment with compound 1 protected against these adverse effects. Recovery of rat liver tissue against DMN-induced hepatocellular necrosis, inflammatory changes and hepatic fibrosis by compound 1 is also confirmed by H&E and Masson stained histopathological evaluation of liver tissue. CONCLUSION: Two xanthones from Swertia punicea exhibited hepatoprotective activities in vitro (compounds 1 and 2) and in vivo (compound 1), respectively.


Sujet(s)
Agents protecteurs , Swertia , Xanthones , Acétaminophène , Animaux , Aspartate aminotransferases/sang , Aspartate aminotransferases/métabolisme , Bilirubine/sang , Tétrachloro-méthane , Survie cellulaire/effets des médicaments et des substances chimiques , N-Méthyl-N-nitroso-méthanamine , Glutathion/métabolisme , Cellules HepG2 , Humains , L-Lactate dehydrogenase/métabolisme , Foie/effets des médicaments et des substances chimiques , Foie/métabolisme , Foie/anatomopathologie , Cirrhose du foie/induit chimiquement , Cirrhose du foie/traitement médicamenteux , Cirrhose du foie/métabolisme , Cirrhose du foie/anatomopathologie , Mâle , Malonaldéhyde/sang , Malonaldéhyde/métabolisme , Agents protecteurs/isolement et purification , Agents protecteurs/pharmacologie , Agents protecteurs/usage thérapeutique , Rat Wistar , Espèces réactives de l'oxygène/métabolisme , Sérumalbumine/analyse , Superoxide dismutase/sang , Superoxide dismutase/métabolisme , Xanthones/isolement et purification , Xanthones/pharmacologie , Xanthones/usage thérapeutique
4.
Arch Pharm Res ; 32(9): 1245-51, 2009 Sep.
Article de Anglais | MEDLINE | ID: mdl-19784581

RÉSUMÉ

Acetylcholinesterase inhibitors (AChEIs) currently form the basis of the newest drugs available for the treatment of Alzheimer's disease. For the aim of screening effective AChEIs, the methanol extracts of the seeds of genus Peganum were found to show significant inhibitory activity of acetylcholinesterase enzyme (AChE) using an in vitro TLC-bioautographic assay. In further studies to seed of P. nigellastrum Bunge, activity-guided fractionation led to the isolation of two new alkaloids nigellastrine I (9) and nigellastrine II (10), and along with eight known alkaloids, vasicinone (1), vasicine (2), harmine (3), deoxyvasicinone (4), deoxyvasicine (5), harmaline (6), harmol (7), harman (8), in which harmol and harman were first isolated from species P. nigellastrum Bunge. As active constituents, all compounds showed good inhibitory activities against AChE. The results of in vitro semi-quality TLC-bioautographic assay showed that harmine, harmaline and harmol displayed a similar AChE inhibitive activities comparing to galanthamine. These results indicated that these alkaloids in P. nigellastrum Bunge could be a potent class of AChEIs.


Sujet(s)
Alcaloïdes/isolement et purification , Anticholinestérasiques/isolement et purification , Chromatographie sur couche mince/méthodes , Peganum/composition chimique , Alcaloïdes/composition chimique , Alcaloïdes/pharmacologie , Anticholinestérasiques/composition chimique , Anticholinestérasiques/pharmacologie , Graines/composition chimique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE